Evidence map›Paper›PMID 28063004›Full record

ArticleMolecular and cellular biochemistry2017

Tubulin alpha 8 is expressed in hepatic stellate cells and is induced in transformed hepatocytes.

Lisa Rein-Fischboeck, Rebekka Pohl, Elisabeth M Haberl, Sebastian Zimny, Maximilian Neumann, Kristina Eisinger, Thomas S Weiss, Sabrina Krautbauer, Christa Buechler

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lisa Rein-FischboeckDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Rebekka PohlDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Elisabeth M HaberlDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Sebastian ZimnyDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Maximilian NeumannDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Kristina EisingerDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Thomas S WeissUniversity Children Hospital (KUNO), Regensburg University Hospital, Regensburg, Germany.
Sabrina KrautbauerDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Christa BuechlerDepartment of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany. christa.buechler@klinik.uni-regensburg.de.ORCID http://orcid.org/0000-0002-5635-3994
University Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC). Non-alcoholic steatohepatitis (NASH) is a risk factor for HCC. In mice that are fed with a methionine-choline deficient diet for two weeks to induce advanced murine NASH, we do see increased hepatic levels of TUBA8 protein. In animals given a high-fat diet for 14 weeks or an atherogenic diet for 12 weeks, hepatic TUBA8 is unchanged. TUBA8 is highly expressed in human hepatic stellate cells (HSC) and co-localizes with the HSC marker desmin in the murine liver. Inflammatory (TNF, LPS, IL-6) and profibrotic mediators (TGF-beta) do not regulate TUBA8 in HepG2 cells, primary HSC and the HSC cell line LX-2, when stimulated for 24 h. Agonists of the farnesoid X receptor and peroxisome proliferator activated receptor gamma, which are nuclear receptors involved in NASH and HCC pathophysiology, have no effect on TUBA8 in HepG2 and LX-2 cells. In human HCC tissues of 18 patients TUBA8 is significantly upregulated when compared to the corresponding non-tumorous tissues. Compared to non-transformed hepatocytes, TUBA8 protein is strongly expressed in transformed cells. Thus, TUBA8 is a marker of HSC whose cell number is increased in NASH, while higher levels in HCC may be related to induction of TUBA8 in parenchymal cells.

Indexed as

AgedAged, 80 and overAnimalsCell Line, TumorCell Transformation, NeoplasticCholineDiet, High-FatDisease Models, AnimalHepatic Stellate CellsHep G2 CellsHumansLiver NeoplasmsMaleMethionineMiceMiddle AgedCholineMethionineTUBA8 protein, humanTuba8 protein, mouseTubulinFatty liverHepatocellular carcinomaInflammationLiver fibrosis

Identifiers

PMID28063004
OpenAlexW2570725115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.